A RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, PARALLEL-GROUP PHASE 2 STUDY OF THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF RTA 408 LOTION IN THE TREATMENT OF PATIENTS AT RISK FOR RADIATION DERMATITIS
Principal Investigator(s)
Crownover,Richard L.
Funded by
REATA PHARMACEUTICALS
Research Start Date
Status
Inactive